We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Review
Validation Studies
Discover, Develop & Validate--Advance and Prospect of Tumor Biomarkers.
Clinical Laboratory 2015
Tumor biomarkers can serve as tools for early detection, diagnosis, prognosis, therapeutic target, response predicting, therapy monitoring of tumors or can be used as surrogate endpoints. Their abilities to assist various clinical decisions make them indispensable tools for current oncotherapies. Therefore, in the past decades, significant effort has been put into finding sensitive, specific, noninvasive, inexpensive, and clinically feasible tumor biomarkers. This review will summarize the recent progress made in different kinds of tumor biomarkers, introduce a promising and versatile novel tumor biomarker called DEK oncoprotein, and lastly, discuss the prospects of tumor biomarkers.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app